Weiss has a history of international biomedical research experience. He was director of research and professor of viral oncology at the Institute of Cancer Research at Royal Marsden Hospital London and the president of the Society for General Microbiology.
Weiss is also known helping other organizations. He has held board positions in the KwaZulu-Natal Research Institute of Tuberculosis and HIV in South Africa, Breakthrough Breast Cancer in the United Kingdom and the Foundation for Vaccine Research in Washington, D.C.
“We are delighted that Dr. Weiss, a pioneer in HIV research whose laboratory made seminal findings on the pathogenesis of HIV infection, is rejoining IAVI’s Scientific Advisory Committee to serve as its Chairman,” Margaret McGlynn, president and CEO of IAVI, said. “In this capacity, Dr. Weiss will lead a newly reconstituted SAC to provide scientific and strategic advice and counsel to IAVI’s research and development efforts aimed at accelerating global efforts in HIV vaccine development.”
Weiss will also serve as the SAC representative to the IAVI Board of Directors. His appointment to the chair of IAVI’s Scientific Advisory Committee started on July 1 and will run through June 30, 2016.